Advertisement
Diagnostics
Subscribe to Diagnostics
View Sample

FREE Email Newsletter

AHRA 2011: Malpractice Suits Down, but Potential Liability Lingers

August 17, 2011 6:36 am | by Diagnostic Imaging | News | Comments

GRAPEVINE, TEXAS - Facing a medical malpractice lawsuit can be a daunting, years-long process. But Detroit lawyer David M. Ottenwess had some simple, initial advice for radiology managers: Don't panic.

AHRA 2011: Industry Slow to Colombini MRI Lessons?

August 17, 2011 6:35 am | by Diagnostic Imaging | News | Comments

GRAPEVINE, TEXAS - A decade after a 6-year-old boy died in a freak MRI accident, what have medical regulators done to ensure greater MRI safety?

Femasys and Norgenix Announce Distribution Agreement for Groundbreaking New Device for Infertility Diagnosis

August 16, 2011 9:41 am | by Bio-Medicine.Org | News | Comments

SPARTANBURG, S.C., Aug. 16, 2011 /- Femasys Inc. and Norgenix Pharmaceuticals, LLC today announced an agreement for exclusive distribution rights in the United States as well as US territories and military bases for Femasys' FemVue™ Saline-Air Device. This FDA cleared device is used...

Advertisement

Childbearing May Increase Risk of Hormone Receptor-Negative Breast Cancer in African-American Women

August 16, 2011 9:40 am | by AACR | News | Comments

Tweet •    Two or more full-term births put African-American women at higher risk.•    Increased risk occurred only in women who did not breast-feed. PHILADELPHIA — African-American women are at higher risk for hormone receptor-negative...

QIAGEN and Pfizer Partner to Develop Companion Diagnostic for Novel Compound in Global Clinical Trials for Lung Cancer

August 15, 2011 11:40 pm | by Bio-Medicine.Org | News | Comments

GERMANTOWN, Maryland and HILDEN, Germany, August 16, 2011 /-   Diagnostic-therapeutic combination aims to improve standard of care for patients with non-small cell lung cancer (NSCLC) Molecular test for KRAS gene mutations holds potential to help determine whether there is a subset...

Prometheus and the Medco Research Institute® to Evaluate the Use of Prometheus' Thiopurine Metabolite Testing for Optimizing Treatment of Inflammatory Bowel Disease Patients

August 15, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO and FRANKLIN LAKES, N.J., Aug. 15, 2011 /- Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostics company that is part of Nestle Health Science, and the Medco Research Institute®, LLC, a wholly-owned subsidiary of Medco Health Solutions, Inc. (NYSE: MHS ),...

Millennium HealthCare Inc. Engages KBL, LLP

August 15, 2011 9:36 am | by Bio-Medicine.Org | News | Comments

SYOSSET, N.Y., Aug. 15, 2011 /- Millennium HealthCare Inc. (Symbol: MHCC) announced today that it has engaged KBL, LLP, a Public Company Accounting Oversight Board (PCAOB) accounting firm as the Company's accountant and advisor. KBL, LLP provides a combination of technology, intellectual...

Childhood Cancer Survivors in Poor Health at Greater Risk for Unemployment in Adulthood

August 15, 2011 9:36 am | by AACR | News | Comments

Tweet •    Poor health led to an eightfold higher risk for unemployment. •    Those with neurocognitive deficits less likely to hold professional positions.•    Neurocognitive limitations affected women’s occupation...

Advertisement

Quest Diagnostics Declares Quarterly Cash Dividend

August 13, 2011 9:40 pm | by Bio-Medicine.Org | News | Comments

MADISON, N.J., Aug. 12, 2011 /- Quest Diagnostics Incorporated (NYSE: DGX ), the world's leading provider of diagnostic testing, information and services, today announced that its Board of Directors declared a quarterly cash dividend of $0.10 per share, payable on October 24, 2011,...

Conserving Your Momentum

August 13, 2011 8:33 am | by Diagnostic Imaging | News | Comments

Remember your education in physics? No, not the stuff from your radiology residency; I'm talking about undergraduate classes, or even earlier. Chances are you thought more than a couple of times about how irrelevant this stuff was going to be, once you got into med school. I know I did.

Chairman of Global Guide to COPD Diagnosis Committee Visited West China Hospital

August 11, 2011 9:42 am | by Bio-Medicine.Org | News | Comments

CHENGDU, China, Aug. 11, 2011 /PRNewswire-Asia/ -- Recently, Professor Rodriguez-Roisin, the first and present Chairman of the Global Initiative Committee for Chronic Obstructive Pulmonary Disease, the first Chairman of the European Respiratory Society, and also the Dean of the medical...

Concord Medical and GE Healthcare Sign MOU for Preferred Partnership in China

August 11, 2011 6:41 am | by Bio-Medicine.Org | News | Comments

BEIJING, Aug. 11, 2011 /PRNewswire-Asia-FirstCall/ -- Concord Medical Services Holdings Limited ("Concord Medical" or the "Company") (NYSE: CCM ), the operator of the largest network of radiotherapy and diagnostic imaging centers in China, today announced that it has signed an Memorandum...

U.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study

August 11, 2011 4:40 am | by PositiveID | News | Comments

U.S. Department of Homeland Security Validates Performance of PositiveID Corporation's Multiplex BioThreat Assay Through an In-House Blind Study

Advertisement

A Case for Prior Authorization of Imaging Services

August 10, 2011 9:37 pm | by Diagnostic Imaging | News | Comments

The head of a speciality benefit management company gives his take on why prior authorization is the only system that ensures that vast data is seriously considered in patient diagnosis and treatment.

Enigma Diagnostics and GSK Announce Collaboration on Assay Development and Commercialization of Enigma's ML Platform

August 10, 2011 7:38 am | by Bio-Medicine.Org | News | Comments

LONDON and OXFORD, England, Aug. 10, 2011 /- Enigma Diagnostics Limited (Enigma) and GlaxoSmithKline (GSK) today announced that they have signed agreements for the supply and commercialization on an exclusive basis of the Enigma® ML system in Europe and other designated key...

CT Study Stratifies Death Risk of Coronary Artery Disease

August 10, 2011 5:39 am | by Diagnostic Imaging | News | Comments

A study assessing CT angiographs of nearly 25,000 patients presumed to be free of coronary artery disease (CAD) has shown both obstructive and nonobstructive forms of the disease to increase the risk of death.

DNA and RNA Probes: Preparation, Formats, Labeling, Amplification, Detection

August 9, 2011 4:39 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Aug. 9, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: DNA and RNA Probes: Preparation, Formats, Labeling, Amplification, Detection...

Marken Announces Appointment of Christopher O'Connell as New Chief Financial Officer

August 9, 2011 4:38 am | by Bio-Medicine.Org | News | Comments

LONDON, Aug. 9, 2011 /- Marken Ltd., a leading life sciences supply chain management organization, today announced the appointment of Christopher O'Connell as their new Chief Financial Officer (CFO) effective August 1, 2011. Mr. O'Connell joins Marken with more than 20 years experience in...

PositiveID Corporation Appoints Pietro Galassetti, MD, PhD to Its Scientific Advisory Board

August 8, 2011 12:38 pm | by PositiveID | News | Comments

PositiveID Corporation Appoints Pietro Galassetti, MD, PhD to Its Scientific Advisory Board

Reducing Tube Current to Manage CT Radiation Dose

August 8, 2011 11:40 am | by Diagnostic Imaging | News | Comments

Using lower fixed-tube current or automatic exposure control techniques when performing adult and pediatric head CT scans can reduce radiation dose and ease concern about cancer risk, according to a recent study published in the Journal of the American College of Radiology.

PET Parses Alzheimer's, Other Cognitive Impairments

August 8, 2011 8:43 am | by Diagnostic Imaging | News | Comments

Positron emission tomography (PET) scans using F-18 florbetaben (18F-FDG) clearly distinguished patients with Alzheimer's disease from those with frontaltemporal lobar degeneration (FTLD) and other cognitive impairments, according to a study in the Journal of Nuclear Medicine.

Saladax Biomedical, Inc. Enters Agreement with Kaan Medikal for Distribution of My5-FU in Turkey

August 8, 2011 8:43 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., Aug. 8, 2011 /- Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Kaan Medikal will serve as the exclusive...

Alere bumps up its stake in Axis-Shield stock

August 8, 2011 6:39 am | by Mass High Tech: The Journal of New England Technology | News | Comments

After confirming Friday its $375 million offer to acquire the outstanding shares of Scottish life sciences company Axis-Shield Plc, Waltham-based Alere Inc. announced today that it has increased its ownership stake of the company's shares from 2.23 percent to 6.4 percent.

Caliper and Carestream Settle Lawsuits

August 8, 2011 6:39 am | by Bio-Medicine.Org | News | Comments

HOPKINTON, Mass., Aug. 8, 2011 /- Caliper Life Sciences, Inc. (NASDAQ: CALP ) today announced that it has favorably settled two lawsuits with Carestream Health, Inc. In the first lawsuit, filed in February 2010, Caliper, its wholly owned subsidiary, Xenogen, and Stanford University...

MRI Safety: Monitoring Body Temperature During MRI

August 6, 2011 6:34 pm | by Diagnostic Imaging | News | Comments

This monograph focuses on the need to monitor body temperature in patients during MRI and discusses the sites to record temperature based on efficacy and stability of the measurement, as well as the response time (i.e., the temporal resolution) during temperature fluctuations.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading